Vous êtes ici : Accueil > Publications du LRT

Publications du LRT

Publié le 18 octobre 2017

​​​​​

  
A kinome-targeted RNAi-based screen links FGF signaling to H2AX phosphorylation in response to radiation.
Benzina S, Pitaval A, Lemercier C, Lustremant C, Frouin V, Wu N, Papine A, Soussaline F, Romeo PH, Gidrol X.
2015
Metabolomics for rheumatic diseases: has the time come?
Semerano L, Romeo PH, Boissier MC.
2015
TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage  activation.
Ferri F, Parcelier A, Petit V, Gallouet AS, Lewandowski D, Dalloz M, van den Heuvel A, Kolovos P, Soler E, Squadrito ML, De Palma M, Davidson I, Rousselet G, Romeo PH.
2015
Bio-engineered and native red blood cells from cord blood exhibit the same metabolomic  profile.
Darghouth D, Giarratana MC, Oliveira L, Jolly S, Marie T, Boudah S, Mario N, Junot C, Douay L, Romeo PH.
2016
Design and functionalities of the MADOR software suite for dose-reduction management  after DTPA therapy
Leprince B, Fritsch P, Berard P, Romeo PH.
2016
TNFSF10/TRAIL regulates human T4 effector memory lymphocyte radiosensitivity and  predicts radiation-induced acute and subacute dermatitis.
Baijer J, D‚champs N, Perdry H, Morales P, Kerns S, Vasilescu A, Baulande S, Azria D, Romeo PH, Schmitz A.
2016
P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis.
Spangrude GJ, Lewandowski D, Martelli F, Marra M, Zingariello M, Sancillo L, Rana RA, Migliaccio AR.
2016
Macrophage production and activation are dependent on TRIM33
Gallouet A.S., Ferri F., Petit V., Parcelier A., Lewandowski D., Gault N., Barroca V., Le Gras S., Soler E., Grosveld F., Davidson I. and Romeo PH.
2017
Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
Corbineau S, Lassalle B, Givelet M, Souissi-Sarahoui I, Firlej V, Romeo PH, Allemand I, Riou L, Fouchet P.
2017
Hopes of high dose-rate radiotherapy
Fouillade C, Favaudon V, Vozenin MC, Romeo PH, Bourhis J, Verrelle P, Devauchelle P, Patriarca A, Heinrich S, Mazal A, Dutreix M.
2017
Paternal Insulin-like Growth Factor 2 (Igf2) regulates Stem Cell Activity During Adulthood
Barroca V, Lewandowski D, Jaracz-Ros A, Hardouin SN.
2017
Death receptor pathways mediate targeted and non-targeted effects of ionizing radiations in breast cancer cells.
Luce A, Courtin A, Levalois C, Altmeyer-Morel S, Romeo PH, Chevillard S, Lebeau J.
2009
Puma and Trail/Dr5 pathways control radiation-induced apoptosis in distinct populations of testicular progenitors.
Coureuil M, Ugolin N, Tavernier M, Chevillard S, Barroca V, Fouchet P, Allemand I.
2010
In vitro assessment of plutonium uptake and release using the human macrophage-like THP-1 cells.
Van der Meeren A, Moureau A, Laurent D, Laroche P, Angulo JF
2016
Penetration and decontamination of americium-241 ex vivo using fresh and frozen pig skin.
Tazrart A., Bolzinger M.A., Moureau A., Molina T., Coudert S., Angulo J.F., Briancon S., Griffiths N.M.
2016
Organ Dose Estimates for Hyperthyroid Patients Treated with (131)I: An Update of the Thyrotoxicosis Follow-Up Study.
Melo D.R., Brill A.B., Zanzonico P., Vicini P., Moroz B., Kwon D., Lamart S., Brenner A., Bouville A., Simon S.L.
2016
S values for 131I based on the ICRP adult voxel phantoms.
Lamart S., Simon SL., Bouville A., Moroz B.E., Lee C.
2016
Body size-specific effective dose conversion coefficients for ct scans.
Romanyukha A., Folio L., Lamart S., Simon S.L., Lee C.
2016
Reconstruction of organ dose for external radiotherapy patients in retrospective epidemiologic studies.
Lee C., Jung J.W., Pelletier C., Pyakuryal A., Lamart S., Kim J.O., Lee C.
2016
Decorporation of Pu/Am Actinides by Chelation Therapy: New Arguments in Favor of an Intracellular Component of DTPA Action.
Grémy O., Laurent D., Coudert S., Griffiths N.M., Miccoli L.
2016
Combined drug and surgery treatment of plutonium-contaminated wounds: indications obtained using a rodent model
Griffiths NM, Coudert S, Wilk JC, Renault D, Angulo JF, Van der Meeren A., . Health Phys., 2012, 106(6):638-44.
2012
Evaluation des risques liés aux Nanomatériaux. Enjeux et mise à jour des connaissances
Gaffet E., Nesslany F., Bottero J-Y., Chaskiel P., Doridot F., Fessard V., Flahaut E.,Lacour S., Malard S., Motzkus C., Mouneyrac C., Ricaud M., Rouxel D., Sanh A., Van Der Meeren A. Edition: ANSES – Rapport d’expertise collective, Publisher: ANSES, 2014.
2014
Forecasting the in vivo behavior of radiocontaminants of unknown physicochemical properties using a simple in vitro test
Griffiths NM, Coudert S, Moureau A, Laroche P, Angulo JF, Van der Meeren A. ,
2015
Developing a physiologically based approach for modeling plutonium decorporation therapy with DTPA
Kastl M, Giussani A, Blanchardon E, Breustedt B, Fritsch P, Hoeschen C, Lopez MA
2014
Macrophages as key elements of Mixed-oxide [U-Pu(O-2)] distribution and pulmonary damage after inhalation?
van der Meeren A, Moureau A, Griffiths NM
2014
Medical countermeasures after a radiological event  An update from the CATO project
Leiterer A, Bardot I, Menetrier F, Bardot S, Gremy O, Berard P, Pech A, Favaro P
2014
Actinide handling after wound entry with local or systemic decorporation therapy in the rat
Griffiths NM, Coudert S, Renault D, Wilk JC, van der Meeren A
2014
Increased retention of americium in kidneys as compared with plutonium in an actinide wound contamination model in the rat.
Griffiths NM, Coudert S, Molina T, Wilk JC, Renault D, Berard P, van der Meeren A
2014
Macrophages as key elements of Mixed-oxide [U-Pu(O2)] distribution and pulmonary damage after inhalation?
van der Meeren A, Moureau A, Griffiths N M
2014
COMBINED DRUG AND SURGERY TREATMENT OF PLUTONIUM-CONTAMINATED WOUNDS  INDICATIONS OBTAINED USING A RODENT MODEL
Griffiths NM, Coudert S, Wilk JC, Renault D, Angulo JF, van der Meeren A
2014
1 - 30Suivante